Comparison of Nine Phenotypic Methods for Detection of Extended-Spectrum β-Lactamase Production by Enterobacteriaceae

被引:118
作者
Garrec, Helene [2 ,3 ]
Drieux-Rouzet, Laurence [2 ,3 ]
Golmard, Jean-Louis [4 ,5 ]
Jarlier, Vincent [2 ,3 ]
Robert, Jerome [1 ,2 ,3 ]
机构
[1] UPMC Paris 6, Lab Bacteriol Hyg, UFR Med Pierre & Marie Curie, Fac Med Pierre & Marie Curie, F-75634 Paris 13, France
[2] Fac Med Pierre & Marie Curie, UMR9, Paris, France
[3] CHU Pitie Salpetriere, AP HP, Lab Bacteriol Hyg, Paris, France
[4] Fac Med Pierre & Marie Curie, Dept Biostat & Informat Med, Paris, France
[5] Fac Med Pierre & Marie Curie, EA3974, Paris, France
关键词
ESCHERICHIA-COLI; FAMILY ENTEROBACTERIACEAE; ETEST; RESISTANCE; EMERGENCE; STRAINS; MEMBERS; TESTS; DISK;
D O I
10.1128/JCM.02130-10
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学];
摘要
The detection of extended-spectrum beta-lactamase-producing (ESBL) bacteria is of importance for infection control and epidemiological surveillance. We aimed to compare phenotypic methods available in the routine laboratory and to evaluate two-step strategies using these methods for the detection of ESBL-positive Enterobacteriaceae. Two methods used for routine susceptibility testing (Vitek2 and disk diffusion methods) and seven methods designed for the detection of ESBL production (ESBL Etests, combination disks, double-disk synergy [DDS] methods on Mueller-Hinton [MH] agar and cloxacillin-containing MH agar, and the Cica-Beta test) were tested against 107 strains of Enterobacteriaceae not susceptible to extended-spectrum cephalosporins. All strains were screened for the presence of acquired ESBL-encoding genes by PCR, and the PCR result was considered the gold standard for evaluation of the other test methods. Among the 107 strains, 52 (49%) were ESBL positive. With Vitek2, sensitivities were the highest when using extended cards (73% to 79%), but 25% to 31% of the strains yielded indeterminate results. For the disk diffusion method, sensitivities were the highest (96%) when testing at least cefotaxime, cefepime, and a third compound (ceftazidime, cefpodoxime, or aztreonam). For the specific methods, specificities ranged from 62% (ceftazidime ESBL Etest) to 100% (DDS using a disk spacing of 20 mm). When a method designed for ESBL detection was used on strains considered ESBL negative or with an indeterminate result by a first routine susceptibility method, sensitivities reached 100% for a majority of combinations. In conclusion, two-step strategies using phenotypic methods available in most clinical laboratories may reach a sensitivity of 100% for ESBL detection among a large panel of species, including AmpC producers, providing a sensible choice of tests.
引用
收藏
页码:1048 / 1057
页数:10
相关论文
共 36 条
[1]
[Anonymous], BREAKP TABL INT MIC
[2]
[Anonymous], QSOP51 HLTH PROT AG
[3]
[Anonymous], REC 2010
[4]
Biggerstaff BJ, 2000, STAT MED, V19, P649, DOI 10.1002/(SICI)1097-0258(20000315)19:5<649::AID-SIM371>3.0.CO
[5]
2-H
[6]
Growing group of extended-spectrum β-lactamases:: The CTX-M enzymes [J].
Bonnet, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) :1-14
[7]
Incidence of class A extended-spectrum β-lactamases in Champagne-Ardenne (France):: a 1 year prospective study [J].
Brasme, L. ;
Nordmann, P. ;
Fidel, F. ;
Lartigue, M. F. ;
Bajolet, O. ;
Poirel, L. ;
Forte, D. ;
Vernet-Garnier, V. ;
Madoux, J. ;
Reveil, J. C. ;
Alba-Sauviat, C. ;
Baudinat, I. ;
Bineau, P. ;
Bouquigny-Saison, C. ;
Eloy, C. ;
Lafaurie, C. ;
Simeon, D. ;
Verquin, J. P. ;
Noel, F. ;
Strady, C. ;
De Champs, C. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (05) :956-964
[8]
Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002-2005 [J].
Cambau, E. ;
Lascols, C. ;
Sougakoff, W. ;
Bebear, C. ;
Bonnet, R. ;
Cavallo, J. -D. ;
Gutmann, L. ;
Ploy, M. -C. ;
Jarlier, V. ;
Soussy, C. -J. ;
Robert, J. .
CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (10) :1013-1020
[9]
Detection of extended-spectrum β-lactamases in klebsiellae with the oxoid combination disk method [J].
Carter, MW ;
Oakton, KJ ;
Warner, M ;
Livermore, DM .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (11) :4228-4232
[10]
Clinical and Laboratory Standards Institute, 2010, M100S20